| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/11/2008 | US20080219946 Therapeutic agent and method for ovulation disorder caused by luteinized unruptured follicle |
| 09/11/2008 | US20080219924 Imaging, diagnosis and treatment of disease |
| 09/11/2008 | US20080219919 Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 09/11/2008 | US20080217820 Tissue scaffold having aligned fibrils, apparatus and method for producing the same, and artificial tissue and methods of use thereof |
| 09/11/2008 | DE102007012276A1 Zusammensetzung zur Behandlung von Knochen- und/oder Knorpeldefekten Composition for the treatment of bone and / or cartilage defects |
| 09/10/2008 | EP1967587A1 APO-3 Ligand |
| 09/10/2008 | EP1967586A1 84P2A9: A prostate and testis specific protein highly expressed in prostate cancer |
| 09/10/2008 | EP1967528A2 CDR-Grafted type III anti-cea humanized mouse monoclonal antibodies |
| 09/10/2008 | EP1967526A1 Inhibitor of TGF-ß activation reaction |
| 09/10/2008 | EP1967525A2 A method for regulating immune function in primates using the foxp3 protein |
| 09/10/2008 | EP1967524A1 Methods for producing ACE-inhibitory peptides from whey and peptides obtained thereby |
| 09/10/2008 | EP1967210A1 Novel application of apelin |
| 09/10/2008 | EP1967208A1 THERAPEUTIC AGENT FOR SKIN OR SKIN REPAIR-PROMOTING AGENT COMPRISING GHRELIN, DERIVATIVE THEREOF OR SUBSTANCE CAPABLE OF ACTING ON GHS-R1a AS ACTIVE INGREDIENT |
| 09/10/2008 | EP1967202A1 Use of LHRH Antagonists for the Treatment of Lower Urinary Tract Symptoms, in particular Overactive Bladder and/or Detrusor Overactivity |
| 09/10/2008 | EP1967201A1 Therapeutic agent for skin or skin repair-promoting agent comprising des-acylghrelin or derivative thereof as active ingredient |
| 09/10/2008 | EP1966388A2 Targeting vector-phospholipid conjugates |
| 09/10/2008 | EP1966380A1 Method for preventing and/or treating articles or media contaminated with bacteria of the legionella genus |
| 09/10/2008 | EP1966239A1 Octanoate-reduced human albumin |
| 09/10/2008 | EP1966238A1 Interleukin-12p40 variants with improved stability |
| 09/10/2008 | EP1966235A2 Antimicrobial cathelicidin peptides |
| 09/10/2008 | EP1966234A2 Endometriosis cell targeting peptides and uses thereof |
| 09/10/2008 | EP1965831A2 Use of c1 inhibitor for the prevention of ischemia-reperfusion injury |
| 09/10/2008 | EP1965830A1 Use of alkaline phosphatase to maintain healthy tissue mass in mammals |
| 09/10/2008 | EP1965829A1 Alternative oxidase and uses thereof |
| 09/10/2008 | EP1965828A2 Pharmaceutical formulation for increased epithelial permeability of glucose-regulating peptide |
| 09/10/2008 | EP1965827A2 Treatment of conditions involving demyelination |
| 09/10/2008 | EP1965826A2 Mntf differentiation and growth of stem cells |
| 09/10/2008 | EP1965825A1 Anti hiv-1 active bacterial and baculovirus recombinant epap-1 |
| 09/10/2008 | EP1965824A2 Metabolite derivatives of the hdac inhibitor fk228 |
| 09/10/2008 | EP1965823A2 Methods for administering hypoglycemic agents |
| 09/10/2008 | EP1965820A1 Zingiber plant extract |
| 09/10/2008 | EP1965813A2 Methods of treating fibrosing diseases by induction of immune tolerance |
| 09/10/2008 | EP1965811A2 Device and method for cell grafting |
| 09/10/2008 | EP1729797B1 Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants |
| 09/10/2008 | EP1651247B1 Treatment and diagnosis of neoplasms using thymic stromal lymphopoietin |
| 09/10/2008 | EP1635776B1 Lipidic protein-transfer systems and cosmetic/dermatological use thereof |
| 09/10/2008 | EP1633883B1 Method for assaying lkb1 phosphorylation activity |
| 09/10/2008 | EP1570269A4 Methods of protecting against radiation damage using alpha thymosin |
| 09/10/2008 | EP1478732B1 A selenium yeast product, a method of preparing a selenium yeast product and the use of the product for preparing food, a dietary supplement or a drug |
| 09/10/2008 | EP1474440B1 Coniosulphides and their derivatives, method for their production and use as medicaments |
| 09/10/2008 | EP1451222B1 Proteins with il-6 inhibiting activity |
| 09/10/2008 | EP1441771B1 Aqueous sustained-release formulations of proteins |
| 09/10/2008 | EP1381629B1 RECEPTOR IN THE EDb FIBRONECTIN DOMAIN |
| 09/10/2008 | EP1303284B1 Compositions and methods for the treatment of skin damage |
| 09/10/2008 | EP1246846B1 Soluble interleukin-20 receptor |
| 09/10/2008 | EP1240901B1 Medicinal compositions for treating and preventing diseases based on abnormal blood coagulation |
| 09/10/2008 | EP1237910B1 Trp-protein-related mtr1 protein and dna sequence coding therefor |
| 09/10/2008 | EP1200124B1 Erythropoietin-immunoglobulin fusion proteins |
| 09/10/2008 | EP1159967B1 Tumor vaccines |
| 09/10/2008 | EP1159006B1 Water-soluble compositions of bioactive lipophilic compounds |
| 09/10/2008 | EP1141017B1 Characterization of the soc/crac calcium channel protein family |
| 09/10/2008 | EP1131356B1 Monoclonal anti alpha-D (ITGAD) antibody for use in the treatment of CNS injuries caused by trauma |
| 09/10/2008 | EP1067911B1 Hydrogel compositions useful for the sustained release of macromolecules and methods of making same |
| 09/10/2008 | EP1062232B1 Molecules that home to various selected organs or tissues |
| 09/10/2008 | EP1060247B1 Compositions containing an ox-40 receptor binding agent or a nucleic acid encoding the same and methods for enhancing antigen-specific immune response |
| 09/10/2008 | EP0983767B1 Preventives or remedies for the treatment of multiple sclerosis containing antagonist anti-IL-6-receptor antibodies |
| 09/10/2008 | EP0956039B1 IL-11 signalling for enhancing fertility |
| 09/10/2008 | EP0873415B1 Fusion protein delivery system and uses thereof |
| 09/10/2008 | EP0871376B1 Use of locally administered lysine for enhancing vascular fonction |
| 09/10/2008 | EP0771322B1 Abundant extracellular products and methods for their production and use |
| 09/10/2008 | CN101263156A Novel macrocyclic inhibitors of hepatitis C virus replication |
| 09/10/2008 | CN101262888A Formulations for enhanced mucosal delivery of PYY |
| 09/10/2008 | CN101262886A Formulation and method for administration of ophthalmologically active agents |
| 09/10/2008 | CN101262880A Airway administration of tissue factor pathway inhibitor in inflammatory conditons affecting the respiratory tract |
| 09/10/2008 | CN101262879A Airway administration of activated protein C in inflammatory conditions affecting the respiratory tract |
| 09/10/2008 | CN101262878A Therapeutic combination of HAMLET and a HDAC inhibitor to treat cancer |
| 09/10/2008 | CN101262877A Pharmaceutical compositions comprising a TGF-beta superfamily member |
| 09/10/2008 | CN101262876A Methods for treating B-cell malignancies using a TACI-IG fusion molecule |
| 09/10/2008 | CN101262875A Peptides capable of modulating the function of TIRC7 |
| 09/10/2008 | CN101262874A Stabilized GLP-1 analogs |
| 09/10/2008 | CN101261277A Promyostatin peptides and methods of using same |
| 09/10/2008 | CN101260398A Nerve growth factor gene positioning reconstruction animal and its preparation method and application |
| 09/10/2008 | CN101260157A Fusion polypeptide and application thereof in preparing antineoplastic, antiviral and intracellular bacterial parasite infection curing medicament |
| 09/10/2008 | CN101260154A Novel mhc II associated peptides |
| 09/10/2008 | CN101260151A Separation and primary structure of sea purse blood vessel generation inhibitive factor 1, and application thereof in preparing blood vessel generation inhibiting medicament and antineoplastic medicam |
| 09/10/2008 | CN101260150A Ancylostoma caninum anticoagulant peptide and its preparation and application |
| 09/10/2008 | CN101260147A Modified blood vessel endothelium growth factor polypeptide segment and application thereof |
| 09/10/2008 | CN101259270A Treatment of patients having non-hodgkins lymphoma with bone marrow involvement with anti-CD20 antibodies |
| 09/10/2008 | CN101259265A Deep-sea fish collagen oral liquid |
| 09/10/2008 | CN101259142A Bone peptide injection preparation |
| 09/10/2008 | CN101259120A Methods of inducing terminal differentiation |
| 09/10/2008 | CN101259115A Orally-administered insulin soft capsule for treating diabetes and preparation thereof |
| 09/10/2008 | CN100417727C Medical preparations for treatment of alpha-galactosidase A deficiency |
| 09/10/2008 | CN100417662C Peptide for promoting insulin release of frog and its use in production of drugs |
| 09/10/2008 | CN100417661C Hydrochloride salts of a glycopeptide phosphonate derivative |
| 09/10/2008 | CN100417419C Composition and method to alter lean body mass and bone properties in a subject |
| 09/10/2008 | CN100417418C Nucleic acid-containing complex |
| 09/10/2008 | CN100417412C Liver cell growing promotor injection and its preparation method and application |
| 09/10/2008 | CN100417394C Application of plant extract for preparing medicine to cure bone absorption increment diseases and composition thereof |
| 09/09/2008 | US7423169 Methods for synthesis of acyloxyalkyl derivatives of GABA analogs |
| 09/09/2008 | US7423141 Inhibitors of endothelin-1 synthesis |
| 09/09/2008 | US7423139 Expresion vector comprising nucleotide sequences coding secreted glycoprotein hormone with modified untranslated region for use in enhancement of blood production; directed protein evolution |
| 09/09/2008 | US7423138 Antiproliferative agents; anticancer agents; urogenital systems; insertion into cells |
| 09/09/2008 | US7423130 A nucleic acid sequence encoding the polypeptide, lacking its associated signal peptide |
| 09/09/2008 | US7423129 Antibodies to human eotaxin |
| 09/09/2008 | US7423125 Antibodies to VEGF-C |
| 09/09/2008 | US7423123 Interleukin-9 antagonist muteins and their pharmacological methods of use |
| 09/09/2008 | US7423118 IAPS associated cell cycle proteins, compositions and methods of use |
| 09/09/2008 | US7423116 Pentapeptide compounds and uses related thereto |
| 09/09/2008 | US7423115 Inducing an apoptosis or a killing of a cell, enhancing an effectiveness of cancer chemotherapy |